External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

SLEuro 2024

-
Coming soon
11:20 AM
Duration 10mins Concert Hall
Longitudinal assessment of biomarkers in NOBILITY, a randomized, phase II clinical trial of obinutuzumab for treatment of proliferative lupus nephritis
Richard Furie

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar